Benoît Trottier

5.7k total citations · 1 hit paper
68 papers, 2.2k citations indexed

About

Benoît Trottier is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Benoît Trottier has authored 68 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 40 papers in Virology and 21 papers in Emergency Medicine. Recurrent topics in Benoît Trottier's work include HIV Research and Treatment (40 papers), HIV/AIDS drug development and treatment (39 papers) and HIV/AIDS Research and Interventions (30 papers). Benoît Trottier is often cited by papers focused on HIV Research and Treatment (40 papers), HIV/AIDS drug development and treatment (39 papers) and HIV/AIDS Research and Interventions (30 papers). Benoît Trottier collaborates with scholars based in Canada, United States and United Kingdom. Benoît Trottier's co-authors include Sharon Walmsley, Calvin Cohen, Ralph DeMasi, Keith Henry, Peter J. Piliero, Joseph J. Eron, Jacob Lalezari, John Delehanty, Jain Chung and Mary O’Hearn and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Benoît Trottier

64 papers receiving 2.1k citations

Hit Papers

Enfuvirtide, an HIV-1 Fus... 2003 2026 2010 2018 2003 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America
    2003 716 citations Benoît Trottier, Sharon Walmsley et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Benoît Trottier 1.7k 1.5k 390 374 261 68 2.2k
Peter J. Piliero 1.4k 0.8× 1.2k 0.8× 371 1.0× 342 0.9× 166 0.6× 49 2.0k
Moti Ramgopal 1.1k 0.7× 901 0.6× 418 1.1× 322 0.9× 250 1.0× 83 1.5k
Brian Wynhoven 1.7k 1.0× 1.5k 1.0× 448 1.1× 362 1.0× 130 0.5× 30 2.1k
Hans-Jürgen Stellbrink 1.4k 0.8× 1.1k 0.7× 257 0.7× 584 1.6× 106 0.4× 12 1.7k
Mauro Andreotti 934 0.6× 874 0.6× 442 1.1× 242 0.6× 555 2.1× 99 1.8k
J Aboulker 1.1k 0.6× 1.1k 0.7× 435 1.1× 338 0.9× 254 1.0× 91 1.8k
Vanni Borghi 1.1k 0.6× 910 0.6× 557 1.4× 296 0.8× 313 1.2× 102 1.8k
Scott Hammer 1.3k 0.8× 1.1k 0.8× 280 0.7× 493 1.3× 78 0.3× 23 1.6k
J. M. A. Lange 1.2k 0.7× 1.3k 0.9× 343 0.9× 154 0.4× 184 0.7× 22 1.7k
Laurence Morand‐Joubert 1.4k 0.8× 1.4k 0.9× 543 1.4× 125 0.3× 167 0.6× 96 2.0k

Countries citing papers authored by Benoît Trottier

Since Specialization
Citations

This map shows the geographic impact of Benoît Trottier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoît Trottier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoît Trottier more than expected).

Fields of papers citing papers by Benoît Trottier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoît Trottier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoît Trottier. The network helps show where Benoît Trottier may publish in the future.

Co-authorship network of co-authors of Benoît Trottier

This figure shows the co-authorship network connecting the top 25 collaborators of Benoît Trottier. A scholar is included among the top collaborators of Benoît Trottier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoît Trottier. Benoît Trottier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wong, Alexander, Jason Brunetta, Hugues Loemba, et al.. (2024). Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV from the Canadian cohort of the observational BICSTaR study. Medicine. 103(16). e37785–e37785. 1 indexed citations
3.
Cardinal, Marie‐Hélène Roy, Madéleine Durand, Carl Chartrand‐Lefebvre, et al.. (2023). Differential Impact of IL-32 Isoforms on the Functions of Coronary Artery Endothelial Cells: A Potential Link with Arterial Stiffness and Atherosclerosis. Viruses. 15(3). 700–700. 4 indexed citations
4.
Dupuy, Franck P., Marc Messier-Peet, Madéleine Durand, et al.. (2023). The Frequency and Function of NKG2C+CD57+ Adaptive NK Cells in Cytomagalovirus Co-Infected People Living with HIV Decline with Duration of Antiretroviral Therapy. Viruses. 15(2). 323–323. 2 indexed citations
5.
Royston, Léna, Stéphane Isnard, Nils Perrin, et al.. (2022). Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV. Frontiers in Cardiovascular Medicine. 9. 964650–964650. 6 indexed citations
6.
Routy, Jean‐Pierre, Cécile Tremblay, Réjean Thomas, et al.. (2020). Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers. Frontiers in Immunology. 11. 583820–583820. 7 indexed citations
7.
Yong, Chan‐Loi, Joseph Gathe, Catherine Orrell, et al.. (2017). Pharmacokinetic analysis of nevirapine extended release 400 mg once daily vs nevirapine immediate release 200 mg twice daily formulation in treatment-naïve patients with HIV-1 infection. HIV Clinical Trials. 18(5-6). 189–195. 3 indexed citations
8.
DeJesus, Edwin, Michael T. Yin, Frank Post, et al.. (2015). P030: Renal and bone safety of tenofovir alafenamide versus tenofovir disoproxil fumarate. Journal of the International AIDS Society. 18(3 (Suppl 2)). 9 indexed citations
9.
Thomas, Réjean, Chrissi Galanakis, Sylvie Vézina, et al.. (2015). Adherence to Post-Exposure Prophylaxis (PEP) and Incidence of HIV Seroconversion in a Major North American Cohort. PLoS ONE. 10(11). e0142534–e0142534. 47 indexed citations
10.
Trottier, Benoît, Danièle Longpré, Sylvie Vézina, et al.. (2014). Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: 96 weeks post VERITAS study. Journal of the International AIDS Society. 17(4S3). 19815–19815. 1 indexed citations
11.
Routy, Jean‐Pierre, Jonathan B. Angel, Johanna N. Spaans, et al.. (2012). Design and Implementation of a Randomized Crossover Study of Valproic Acid and Antiretroviral Therapy to Reduce the HIV Reservoir. HIV Clinical Trials. 13(6). 301–307. 11 indexed citations
12.
Rouleau, Danielle, Claude Fortin, Benoît Trottier, et al.. (2011). Antiretroviral therapy for adults infected with HIV: Guidelines for health care professionals from the Quebec HIV care committee. Canadian Journal of Infectious Diseases and Medical Microbiology. 22(2). 52–60. 4 indexed citations
13.
Machouf, Nimâ, Rebecca F. O’Brien, Sylvie Vézina, et al.. (2011). P1-S2.52 Risk factors for STIs among MSM attending a sexually transmitted disease clinic in Montreal, Canada. Sexually Transmitted Infections. 87(Suppl 1). A144.3–A144. 5 indexed citations
14.
Klein, Marina B., Jean-Guy Baril, Claude Fortin, et al.. (2011). Management and Treatment of Hepatitis B Virus in Patients with Hiv Infection: A Practical Guide for Health Care Professionals. Canadian Journal of Infectious Diseases and Medical Microbiology. 22(3). 88–96. 5 indexed citations
15.
Trottier, Benoît, Giovanni Di Perri, José Valdez Madruga, et al.. (2010). Impact of the Background Regimen on Virologic Response to Etravirine: Pooled 48-Week Analysis of DUET-1 and -2. HIV Clinical Trials. 11(4). 175–185. 9 indexed citations
16.
Lalonde, R, Réjean Thomas, Anita Rachlis, et al.. (2009). Successful implementation of a national HLA‐B*5701 genetic testing service in Canada. Tissue Antigens. 75(1). 12–18. 21 indexed citations
17.
Walmsley, Sharon, Anona Thorne, Mona Loutfy, et al.. (2007). A Prospective Randomized Controlled Trial of Structured Treatment Interruption in HIV-Infected Patients Failing Highly Active Antiretroviral Therapy (Canadian HIV Trials Network Study 164). JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(4). 418–425. 11 indexed citations
18.
Côté, Pierre, Jean-Guy Baril, Marina B. Klein, et al.. (2007). Management and Treatment of Hepatitis C Virus in Patients with HIV and Hepatitis C Virus Coinfection: A Practical Guide for Health Care Professionals. Canadian Journal of Infectious Diseases and Medical Microbiology. 18(5). 293–303. 12 indexed citations
19.
Gathe, Joseph, David A. Cooper, Charles Farthing, et al.. (2006). Efficacy of the Protease Inhibitors Tipranavir plus Ritonavir in Treatment-Experienced Patients: 24-Week Analysis from the RESIST-1 Trial. Clinical Infectious Diseases. 43(10). 1337–1346. 67 indexed citations
20.
Baril, Jean-Guy, Roger LeBlanc, François Laplante, et al.. (2005). HIV‐associated Lipodystrophy Syndrome: A Review of Clinical Aspects. Canadian Journal of Infectious Diseases and Medical Microbiology. 16(4). 233–243. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter J. Piliero Breakdown of academic impact, for papers by Moti Ramgopal Breakdown of academic impact, for papers by Brian Wynhoven Breakdown of academic impact, for papers by Hans-Jürgen Stellbrink Breakdown of academic impact, for papers by Mauro Andreotti Breakdown of academic impact, for papers by J Aboulker Breakdown of academic impact, for papers by Vanni Borghi Breakdown of academic impact, for papers by Scott Hammer Breakdown of academic impact, for papers by J. M. A. Lange Breakdown of academic impact, for papers by Laurence Morand‐Joubert
Rankless by CCL
2026